[Total pelvic exenteration].
Abstract
Over the last decades total pelvic exenteration (TPE) has evolved into an established and safe surgical technique for locally advanced pelvic malignancies. Depending on the type of cancer 5 year overall survival rates of up to 66% and a satisfactory postsurgical quality of life have been reported. Currently infiltration of the pelvic side wall and resectable metastases are not necessarily a contraindication to a curative approach; furthermore, TPE can also be useful in palliative surgery. In locally recurrent rectal cancer TPE is the treatment of choice if the tumor is deemed resectable. A multidisciplinary diagnostic and therapeutic approach is of utmost importance, hence patients should be treated in specialized centers.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | pelvic
|
scispacy | 1 | ||
| 약물 | TPE
→ total pelvic exenteration
|
scispacy | 1 | ||
| 질환 | TPE
→ total pelvic exenteration
|
scispacy | 1 | ||
| 질환 | pelvic malignancies
|
scispacy | 1 | ||
| 질환 | cancer
|
C0006826
Malignant Neoplasms
|
scispacy | 1 | |
| 질환 | tumor
|
C0027651
Neoplasms
|
scispacy | 1 | |
| 질환 | rectal cancer TPE
|
scispacy | 1 | ||
| 기타 | wall
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 |
MeSH Terms
Female; Humans; Neoplasm Recurrence, Local; Palliative Care; Pelvic Exenteration; Postoperative Complications; Plastic Surgery Procedures; Rectal Neoplasms; Surgery, Plastic; Survival Rate; Ureter; Uterine Cervical Neoplasms